The types of drugs targeting GCGR for the treatment of T2DM include small-molecule antagonists, polypeptides [8,9], monoclonal antibodies [10,11,12], and antisense oligonucleotides [13,14]. The gene discussed is GCGR; the disease is type 2 diabetes mellitus.